People · Operator
Named in public records as an officer, director or promoter · active 2013–2014 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Dual Therapeutics, LLC | — | Pharmaceuticals | Series A | $11.0M | $197.5M | 2013 |
| Orca Pharmaceuticals, LLC | — | Pharmaceuticals | Seed | $4.6M | $99.3M | 2013 |
| Abeona Therapeutics LLC | — | Pharmaceuticals | Seed | $3.6M | $137.4M | 2014 |
Al Hawkins at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Al Hawkins on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Baiju Shah | 2 | 8 |
| David U'Prichard | 2 | 4 |
| Timothy Miller | 1 | 4 |
| Michael Hunter | 1 | 3 |
| Theodore Torphy | 1 | 2 |
| Thomas Facklam | 1 | 1 |
| Michael Ohlmeyer | 1 | 1 |
| Roy Pettipher | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.